Stock Exchange
Genmab A/S is listed on the NASDAQ OMX Copenhagen A/S and is a member of the Nordic Large Cap index.
ID code/ISIN: DKK0010272202
Stock Symbol: GEN
Stock Information
Number of shares: 44,907,142
Nominal value per share: DKK 1
Share capital: DKK 44,907,142
Shareholders holding more than 5% of the shares:
Glaxo Group Ltd.
Hendrikus Hubertus Franciscus Stienstra (partly through Mercurius Beleggingsmaatschappij B.V. and Stimex Participatiemaatschappij B.V.)
ATP and ATP Invest
| Subsidiary Companies |
Genmab B.V. (Netherlands) |
|
Genmab, Inc. (United States) |
|
Genmab MN, Inc. (United States) |
|
Genmab Ltd. (United Kingdom) |
| |
|
| Auditors |
PricewaterhouseCoopers |
| |
|
| Principal Law Firms |
Shearman & Sterling LLP |
|
Kromann Reumert
|
| Financial Calendar |
| March 2, 2010 |
Publication of the Financial Statement Release for 2009 |
| March 23, 2010 |
Publication of the Annual Report for 2009 |
| April 21, 2010 |
Annual General Meeting 2010 |
| May 11, 2010 |
Publication of the Interim Report for the first quarter 2010 |
| August 17, 2010 |
Publication of the Interim Report for the first half 2010 |
| November 9, 2010 |
Publication of the Interim Report for the first nine months 2010 |
| Key Dates |
|
| Founded |
Founded 1999 |
| First capitalization |
February 25, 1999 |
| IPO |
October 18, 2000 |
| Private Placement |
July 1, 2004 |
| Private Placement |
January 27, 2006 |
| Most recent Annual Report |
March 23, 2010 |
| Most recent Annual General Meeting |
April 21, 2010 |
| Financial Calendar year-end |
December 31, 2010 |
Election results of the Annual General Meeting 2010